生物制品板块1月9日涨1.73%，智翔金泰领涨，主力资金净流入1.44亿元

Group 1 - The biopharmaceutical sector increased by 1.73% on January 9, with Zhixiang Jintai leading the gains [1] - The Shanghai Composite Index closed at 4120.43, up 0.92%, while the Shenzhen Component Index closed at 14120.15, up 1.15% [1] - Key stocks in the biopharmaceutical sector showed significant price increases, with Zhixiang Jintai rising by 11.17% to a closing price of 32.44 [1] Group 2 - The biopharmaceutical sector experienced a net inflow of 144 million yuan from institutional investors, while retail investors saw a net inflow of 90.72 million yuan [2] - Major stocks like Wozhen Bio and Wanze Co. had notable net inflows from institutional investors, with Wozhen Bio seeing 108 million yuan [3] - Retail investors showed a net outflow in several stocks, indicating a mixed sentiment in the market [3]